Octapharma Brazil

Octapharma’s core business is the development, production and sale of safe and effective medicines derived from human proteins in the following areas:
• Haematology (coagulation disorders)
• Immunotherapy (immune disorders)
• Intensive Care and Emergency Medicine

Octapharma is an independent, Swiss-based company founded in 1983 by Mr. Wolfgang Marguerre.

The Group has since grown to include six state-of-the-art production plants in Austria, France, Germany, Sweden and Mexico, 54 Plasma Donation Centres in the US and in Europe as well as 37 subsidiaries and representative offices. With over 4,000 employees, Octapharma currently makes sales in over 80 countries, including Brazil, where the company has been present since 1993.

Type: EXECUTIVE
Address: AVENIDA AYRTON SENNA, 1850 LOJA 118 BARRA DA TIJUCA - CEP 22775-001 RIO DE JANEIRO - RJ
Website: http://www.octapharma.com
Phone: 21 24303183
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.